Maysa Abu-Khalaf MBBS, MD
Associate Professor of Medicine (Medical Oncology) and of Obstetrics, Gynecology, and Reproductive Sciences
Clinical trials evaluating novel agents for the treatment of breast, ovarian and endometrial cancers; PI3K-mTOR inhibitors; HER-2 targeted therapies; angiogenesis
Dr. Abu-Khalaf's major research interest is designing and conducting clinical trials evaluating novel treatments for breast, ovarian and endometrial cancers.
Extensive Research Description
Dr. Abu-Khalaf works in close collaboration with members of the Departments of Surgery, Therapeutic Radiology and Diagnostic Radiology to develop integrated clinical programs for patients with breast and gynecologic cancers. She is a member of the the Yale Cancer Center Developmental Therapeutics program. Dr.Abu-Khalaf designs and conducts early phase clinical trials evaluating novel treatment strategies for patients with breast and gynecologic cancers.